Willa Hsueh, MD: GLP-1 Receptor Agonists for Obesity and Associated Complications

Dr. Willa Hsueh highlights GLP-1 receptor agonists as blockbuster treatments for obesity, type 2 diabetes, and various associated health issues. To manage common gastrointestinal side effects, she noted that physicians recommend advancing doses slowly, maintaining hydration, following diet guidelines, and engaging in both cardio and strength training. Patients are also advised to ensure proper protein, mineral, and vitamin intake to protect against muscle loss and nutritional deficiencies. When discontinuing treatment, gradual dose tapering along with ongoing exercise, proper nutrition, or supportive medications can help prevent weight regain.